☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
ImaginAb
ImaginAb Signs a Multi-Year Non-Exclusive License Agreement with Boehringer Ingelheim for CD8 ImmunoPET Technology
July 23, 2021
PharmaShots Weekly Snapshots (Jan 25- 29, 2021)
January 29, 2021
Pfizer Signs a License and Supply Agreement with ImaginAb for CD8 ImmunoPET Technology
January 7, 2021
PharmaShots Weekly Snapshot (October 14-18, 2019)
October 21, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.